News from medicago inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Sep 18, 2013, 07:50 ET

Mitsubishi Tanabe Pharma Completes Acquisiton of Medicago

OSAKA, Japan and QUEBEC CITY, Canada, Sept. 18, 2013 /PRNewswire/ - Mitsubishi Tanabe Pharma Corporation (TSE: 4508) ("Mitsubishi Tanabe Pharma"...

Sep 12, 2013, 07:00 ET

Medicago Announces Receipt of Final Court Order and Regulatory Approvals for Arrangement with Mitsubishi Tanabe Pharma

QUEBEC CITY, Sept. 12, 2013 /PRNewswire/ - Medicago Inc. (TSX: MDG; OTCQX: MDCGF) ("Medicago" or the "Company"), a biopharmaceutical company...

Aug 29, 2013, 14:33 ET

Medicago Shareholders Approve Arrangement with Mitsubishi Tanabe Pharma Corporation

QUEBEC CITY, Aug. 29, 2013 /PRNewswire/ - Medicago Inc. (TSX: MDG; OTCQX: MDCGF) ("Medicago" or the "Company"), a biopharmaceutical company...

Aug 19, 2013, 07:00 ET

Medicago Inc. announces leading independent proxy firms recommend voting in favour of the arrangement with Mitsubishi Tanabe Pharma

QUEBEC CITY, Aug. 19, 2013 /PRNewswire/ - Medicago Inc. (TSX: MDG; OTCQX: MDCGF) ("Medicago"), a biopharmaceutical company focused on developing...

Aug 09, 2013, 17:00 ET

Medicago Announces 2013 Second Quarter Financial Results

QUEBEC CITY, Aug. 9, 2013 /PRNewswire/ - Medicago Inc. (TSX: MDG), a biopharmaceutical company focused on developing highly effective and...

Jul 31, 2013, 18:38 ET

Medicago announces special meeting of shareholders to be held on August 29, 2013 to approve the Transaction with Mitsubishi Tanabe Pharma

QUEBEC CITY, July 31, 2013 /PRNewswire/ - Medicago Inc. (TSX: MDG; OTCQX: MDCGF) ("Medicago"), a biopharmaceutical company focused on developing...

Jul 12, 2013, 03:09 ET

Medicago announces agreement to be acquired by Mitsubishi Tanabe Pharma in a transaction valued at $357M

QUÉBEC CITY, July 12, 2013 /PRNewswire/ - Medicago Inc. (TSX: MDG; OTCQX: MDCGF), a biopharmaceutical company focused on developing highly...

Jun 27, 2013, 15:09 ET

Immune Design and Medicago Announce License Agreement and Collaboration to Develop Novel Adjuvanted Pandemic Influenza Vaccines

SEATTLE and QUEBEC CITY, June 27, 2013 /PRNewswire/ - Immune Design, a leader in the field of therapeutic vaccines for cancer, infectious...

Jun 20, 2013, 07:00 ET

Medicago successfully produces plant-based Rotavirus VLP vaccine candidate

-First successful plant-based Rotavirus VLP containing all 4 Major proteins- -International Patent Application filed- QUEBEC CITY, June 20,...

Jun 17, 2013, 07:00 ET

Medicago Granted Patent for Influenza Virus-Like Particles in Plants

QUEBEC CITY, June 17, 2013 /PRNewswire/ - Medicago Inc. (TSX: MDG; OTCQX: MDCGF), a biopharmaceutical company focused on developing highly...

Jun 11, 2013, 07:00 ET

Medicago Receives Authorization from Health Canada and Commences Phase II Clinical Trial for an H5N1 Vaccine

QUEBEC CITY, June 11, 2013 /PRNewswire/ - Medicago Inc. (TSX: MDG; OTCQX: MDCGF), a biopharmaceutical company focused on developing highly...

Jun 06, 2013, 07:04 ET

Medicago is First in the World to Report Positive Interim Results for its H7N9 Pre-Clinical Trial

- The H7 VLP vaccine candidate induces an antibody response after a single dose in mice- QUEBEC CITY, June 6, 2013 /PRNewswire/ - Medicago Inc....

May 09, 2013, 17:05 ET

Medicago Announces 2013 First Quarter Financial Results

QUEBEC CITY, May 9, 2013 /PRNewswire/ -   Medicago Inc. (TSX: MDG), a biopharmaceutical company focused on developing highly effective and...

May 08, 2013, 07:00 ET

Medicago successfully produces VLP vaccine candidate for H7N9 virus responsible for recent influenza outbreak in China

-Medicago Ready to Collaborate with Authorities to Further Study the Potential of this Vaccine to Protect Against H7N9- QUEBEC CITY, May 8, 2013...

Apr 17, 2013, 14:45 ET

Medicago and IDRI Reports Positive Results for its Phase I Clinical Trial for an H5N1 Vaccine

- All three configurations of adjuvant and route of administration exceeded the three CHMP criteria- QUEBEC CITY, and SEATTLE, WA, April 17,...

Apr 09, 2013, 07:00 ET

Medicago and IDRI to present data at the World Vaccine Congress

-Presentation of Positive Interim Phase I Clinical Trial results for an H5N1 Vaccine with GLA Adjuvant- QUEBEC CITY, and SEATTLE, WA, April 9,...

Mar 28, 2013, 17:00 ET

Medicago Announces 2012 Fourth Quarter and Year-End Financial Results

QUEBEC CITY, March 28, 2013 /PRNewswire/ - Medicago Inc. (TSX: MDG), a biopharmaceutical company focused on developing highly effective and...

Feb 26, 2013, 07:00 ET

Medicago Invited to Present at Upcoming U.S. Investor Conferences

QUEBEC CITY, Feb. 26, 2013 /PRNewswire/ - Medicago Inc. (TSX: MDG; OTCQX: MDCGF), a biopharmaceutical company focused on developing highly...

Feb 05, 2013, 07:00 ET

Medicago and Investissement Québec Agree to a Three Year Extension of its $15.3M Loan

QUEBEC CITY, Feb. 5, 2013 /PRNewswire/ - Medicago Inc. (TSX: MDG; OTCQX: MDCGF), a biopharmaceutical company focused on developing highly...

Jan 28, 2013, 07:00 ET

Medicago Inc. and Mitsubishi Chemical Holdings Corporation Enter into a Collaboration to Develop a Next Generation Technology for Plant Production

QUEBEC CITY, Jan. 28, 2013 /PRNewswire/ - Medicago Inc. (TSX: MDG) (OTCQX: MDCGF), a biopharmaceutical company focused on developing highly...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

ReportBuyer
Research and Markets
Investor-Edge